Return On Assets of Arch Therapeutics, Inc. from 31 Mar 2014 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arch Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2014 to 30 Jun 2024.
  • Arch Therapeutics, Inc. Return On Assets for the quarter ending 30 Jun 2024 was -730%, a 138% decline year-over-year.
  • Arch Therapeutics, Inc. annual Return On Assets for 2023 was -362%, a 40% decline from 2022.
  • Arch Therapeutics, Inc. annual Return On Assets for 2022 was -259%, a 83% decline from 2021.
  • Arch Therapeutics, Inc. annual Return On Assets for 2021 was -142%, a 11% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Arch Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -730% -423% -138% 01 Apr 2024 30 Jun 2024
Q1 2024 -490% -221% -82% 01 Jan 2024 31 Mar 2024
Q4 2023 -453% -185% -69% 01 Oct 2023 31 Dec 2023
Q3 2023 -362% -103% -40% 01 Jul 2023 30 Sep 2023
Q2 2023 -307% -84% -37% 01 Apr 2023 30 Jun 2023
Q1 2023 -269% -91% -51% 01 Jan 2023 31 Mar 2023
Q4 2022 -269% -122% -83% 01 Oct 2022 31 Dec 2022
Q3 2022 -259% -117% -83% 01 Jul 2022 30 Sep 2022
Q2 2022 -223% -77% -53% 01 Apr 2022 30 Jun 2022
Q1 2022 -178% -31% -21% 01 Jan 2022 31 Mar 2022
Q4 2021 -147% +15% +9.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -142% +18% +11% 01 Jul 2021 30 Sep 2021
Q2 2021 -146% -14% -11% 01 Apr 2021 30 Jun 2021
Q1 2021 -147% -9.9% -7.2% 01 Jan 2021 31 Mar 2021
Q4 2020 -162% -49% -43% 01 Oct 2020 31 Dec 2020
Q3 2020 -159% -17% -12% 01 Jul 2020 30 Sep 2020
Q2 2020 -132% +8.7% +6.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -137% +1.8% +1.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -114% +55% +32% 01 Oct 2019 31 Dec 2019
Q3 2019 -143% -46% -48% 01 Jul 2019 30 Sep 2019
Q2 2019 -140% -55% -64% 01 Apr 2019 30 Jun 2019
Q1 2019 -139% -60% -77% 01 Jan 2019 31 Mar 2019
Q4 2018 -168% -98% -138% 01 Oct 2018 31 Dec 2018
Q3 2018 -97% -64% -196% 01 Jul 2018 30 Sep 2018
Q2 2018 -86% +34% +28% 01 Apr 2018 30 Jun 2018
Q1 2018 -79% +43% +35% 01 Jan 2018 31 Mar 2018
Q4 2017 -71% +79% +53% 01 Oct 2017 31 Dec 2017
Q3 2017 -33% +120% +79% 29 Sep 2017 02 Oct 2017
Q2 2017 -120% +43% +26% 01 Apr 2017 30 Jun 2017
Q1 2017 -122% +42% +26% 01 Jan 2017 31 Mar 2017
Q4 2016 -149% +17% +10% 01 Oct 2016 31 Dec 2016
Q3 2016 -153% -18% -14% 01 Jul 2016 30 Sep 2016
Q2 2016 -162% -120% -285% 01 Apr 2016 30 Jun 2016
Q1 2016 -164% -221% -388% 01 Jan 2016 31 Mar 2016
Q4 2015 -166% +282% +63% 01 Oct 2015 31 Dec 2015
Q3 2015 -135% +376% +74% 01 Jul 2015 30 Sep 2015
Q2 2015 -42% +507% +92% 01 Apr 2015 30 Jun 2015
Q1 2015 57% +801% 01 Jan 2015 31 Mar 2015
Q4 2014 -448% 01 Oct 2014 31 Dec 2014
Q3 2014 -511% 01 Jul 2014 30 Sep 2014
Q2 2014 -549% 01 Apr 2014 30 Jun 2014
Q1 2014 -744% 01 Jan 2014 31 Mar 2014

Arch Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -362% -103% -40% 01 Oct 2022 30 Sep 2023
2022 -259% -117% -83% 01 Oct 2021 30 Sep 2022
2021 -142% +18% +11% 01 Oct 2020 30 Sep 2021
2020 -159% -17% -12% 01 Oct 2019 30 Sep 2020
2019 -143% -46% -48% 01 Oct 2018 30 Sep 2019
2018 -97% +34% +26% 01 Oct 2017 30 Sep 2018
2017 -130% +23% +15% 01 Oct 2016 30 Sep 2017
2016 -153% -18% -14% 01 Oct 2015 30 Sep 2016
2015 -135% +376% +74% 01 Oct 2014 30 Sep 2015
2014 -511% 01 Oct 2013 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.